Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis

Shamsuddeen A. Aliyu, Ged Avery, Christopher Cawthorne, Stephen J. Archibald, Timor Kadir, Julien M.Y. Willaime, Alyn H. Morice, Simon P. Hart, Michael G. Crooks
European Respiratory Journal 2018 52: 1801138; DOI: 10.1183/13993003.01138-2018
Shamsuddeen A. Aliyu
1Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, UK
2PET Research Centre, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ged Avery
3Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Cawthorne
2PET Research Centre, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Archibald
2PET Research Centre, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timor Kadir
4Optellum Ltd, Oxford Centre for Innovation, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien M.Y. Willaime
5Mirada Medical Ltd, Oxford Centre for Innovation, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyn H. Morice
1Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon P. Hart
1Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon P. Hart
Michael G. Crooks
1Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Textural analysis demonstrates increased heterogeneity of [18F]-FDG uptake in normal lung (on CT) in patients with IPF. Molecular imaging of the lungs using PET can be used to study early disease in IPF before CT abnormalities are apparent. http://ow.ly/T82W30lGU0X

To the Editor:

Recently, positron emission tomography (PET)–computed tomography (CT) imaging in idiopathic pulmonary fibrosis (IPF) has revealed increased [18F]-fluorodeoxyglucose ([18F]-FDG) uptake both in fibrotic lung and areas of lung with a normal radiological appearance on high-resolution computed tomography (HRCT) [1, 2]. IPF is characterised by heterogeneous fibrosis at the tissue level, so to gain insight into the early “microscopic” disease process we used established textural features [3, 4] to evaluate heterogeneity of [18F]-FDG uptake in radiologically normal lung in patients with IPF.

Patients with IPF diagnosed according to international guidelines and who had undergone PET-CT imaging for concomitant cancer diagnosis or staging were identified retrospectively in a single interstitial lung disease (ILD) tertiary referral centre. Controls comprised patients without ILD who had undergone PET-CT imaging for lung cancer (control group 1) or extrathoracic malignancy (control group 2).

PET-CT images were analysed by two experienced radiologists. Four 10-mm diameter regions of interest (ROIs) were placed manually in areas of lung with a normal CT appearance, confirmed by measuring lung density. ROIs were placed away from areas of high FDG uptake (concomitant tumour, mediastinum and diaphragm) to avoid spill-over. [18F]-FDG uptake (standardised uptake value (SUV)) and textural features were extracted within each ROI using XD (Mirada Medical Ltd, Oxford, UK) and proprietary software [5]. Mean and maximum SUV were normalised using body weight. 20 textural features were extracted from each ROI, including first order statistics (FOSs) derived from the grey-level intensity distribution, a measure of grey-level uniformity derived from the Laplacian of Gaussian (LoG) technique for a range of filter sizes (in millimetres), and Laws texture features using two-dimensional convolution masks [3–5]. Paired t-tests were used to compare fibrotic and normal lung in IPF patients. Unpaired t-tests were used to compare normal lung in IPF and controls, using a Bonferroni-corrected α of 0.0025 (0.05/20). Data are presented as mean±sd.

49 PET-CT scans were identified from 16 patients with IPF (13 men and three women; mean±sd age 74.1±10.2 years, forced vital capacity 87±12% predicted and transfer factor of the lung for carbon monoxide 46±14% predicted), 17 lung cancer controls (10 men and seven women; age 61.3±16.4 years) and 16 extrathoracic malignancy controls (nine men and seven women; age 64.5±12.4 years). Lung cancer was the most common reason for PET-CT imaging in IPF patients (11 out of 16). Most extrathoracic malignancy controls had lymphoma or melanoma (11 out of 16).

Areas of radiologically established fibrosis in IPF patients exhibited higher SUV compared to radiologically normal lung in the same patient (maximum SUV 2.1±0.5 versus 1.0±0.3, p<0.001; mean SUV 1.3±0.4 versus 0.8±0.3, p<0.001).

Radiologically normal lung on CT was confirmed by measuring lung density, showing identical Hounsfield units in IPF and controls (data not shown). There were no differences between the two control groups in maximum or minimum SUV in radiologically normal lung. On PET imaging, the SUV in radiologically normal lung in IPF patients was significantly higher than normal lung in pooled controls (maximum SUV 1.0±0.3 versus 0.7±0.2 respectively, p=0.002; mean SUV 0.8±0.3 versus 0.6±0.2, p=0.001).

We found significant differences in heterogeneity of the PET [18F]-FDG signal in normal lung between IPF patients and controls in six textural features (figure 1): LoG uniformity with a 3.84-mm filter (0.77±0.12 versus 0.92±0.10 respectively, p<0.0001); LoG uniformity with a 6.19-mm filter (0.87±0.12 versus 0.98±0.05, p<0.0001); Laws texture L5E5 mean (5.9±2.8×104 versus 2.8±1.4×104, p<0.0001); Laws texture L5L5 standard deviation (2.3±1.5×106 versus 1.1±0.6×106, p<0.001); Laws texture L5E5 standard deviation (2.1±1.2×104 versus 1.0±0.52×104, p<0.0001); and FOS standard deviation (310±199 versus 139±77, p<0.0001). These textural features indicate higher variability in signal intensities within the ROIs in radiologically normal lung in IPF.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Textural analysis of positron emission tomography [18F]-fluorodeoxyglucose signals from normal lung in idiopathic pulmonary fibrosis (IPF) patients and two control groups. Four examples showing significant differences in textural features: a) Laplacian of Gaussian (LoG) uniformity with a 3.84-mm filter (p<0.0001, IPF versus pooled controls), b) Laws texture L5E5 mean (p<0.0001), c) Laws texture L5E5 standard deviation (p<0.0001) and d) first order statistics (FOS) standard deviation (p<0.0001).

IPF is a patchy disease at the tissue level, with areas of new and established fibrosis interspersed with histologically normal lung. As IPF progresses over time, fibrosis spreads to involve previously unaffected lung. Increased [18F]-FDG uptake in radiologically normal lung in patients with IPF [2] has been proposed to reflect increased metabolism in inflammatory cells, erythrocytes or fibroblasts in early injury or fibrosis before structural lung changes become apparent on HRCT [6–8]. Our finding of heterogeneous [18F]-FDG uptake demonstrated by textural analysis in radiologically normal lung in IPF patients supports use of PET imaging to noninvasively identify early “microscopic” disease. We cannot say whether the heterogeneous [18F]-FDG signal represents early injury, inflammation, fibrosis or other processes that would require histological correlation. Redistribution of pulmonary blood flow to normal lung is an unlikely explanation for our findings because there was no increase in CT density, the IPF patients did not have severe disease and we would not expect blood flow to generate a heterogeneous PET signal. A limitation of the present study was the relatively small (10 mm) ROIs which were necessary to avoid spill-over effect and to target only lung that was normal on CT. Our results require confirmation in other populations with early pulmonary fibrosis, including patients with rheumatological disease or subjects in CT screening studies with “interstitial lung abnormalities”. Textural features derived from [18F]-FDG PET are increasingly applied in oncology and tumour heterogeneity is associated with response to therapy [4]. Textural analysis of lung PET-CT imaging is a novel approach that could be used to study early events in IPF pathogenesis, identify early disease, aid prognostication or predict response to therapy.

Footnotes

  • Conflict of interest: S.A. Aliyu has nothing to disclose.

  • Conflict of interest: G. Avery has nothing to disclose.

  • Conflict of interest: C. Cawthorne has nothing to disclose.

  • Conflict of interest: S.J. Archibald has nothing to disclose.

  • Conflict of interest: T. Kadir is an employee and shareholder of Mirada Medical, and an employee, director and shareholder of Optellum Ltd.

  • Conflict of interest: J.M.Y. Willaime is an employee of Mirada Medical.

  • Conflict of interest: A.H. Morice has nothing to disclose.

  • Conflict of interest: S.P. Hart has nothing to disclose.

  • Conflict of interest: M.G. Crooks has nothing to disclose.

  • Received July 3, 2018.
  • Accepted August 24, 2018.
  • Copyright ©ERS 2018

References

  1. ↵
    1. Win T,
    2. Lambrou T,
    3. Hutton B, et al.
    18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging 2012; 39: 521–528.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Win T,
    2. Thomas B,
    3. Lambrou T, et al.
    Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging 2014; 41: 337–342.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Chicklore S,
    2. Goh V,
    3. Siddique M, et al.
    Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging 2013; 40: 133–140.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Hatt M,
    2. Tixier F,
    3. Pierce L, et al.
    Characterization of PET/CT images using texture analysis: the past, the present… any future? Eur J Nucl Med Mol Imaging 2017; 44: 151–165.
    OpenUrl
  5. ↵
    1. Willaime JMY,
    2. Pickup L,
    3. Boukerroui D, et al.
    Impact of segmentation techniques on the performance of a CT texture-based lung nodule classification system. Insights Imaging 2016; 7: Suppl., B-0436.
    OpenUrl
  6. ↵
    1. Bondue B,
    2. Sherer F,
    3. Van Simaeys G, et al.
    PET/CT with 18F-FDG– and 18F-FBEM–labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. J Nucl Med 2015; 56: 127–132.
    OpenUrlAbstract/FREE Full Text
    1. Amara N,
    2. Goven D,
    3. Prost F, et al.
    NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGF-β1-induced fibroblast differentiation into myofibroblasts. Thorax 2010; 65: 733–738.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Matsusaka Y,
    2. Nakahara T,
    3. Takahashi K, et al.
    18F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats. EJNMMI Res 2017; 7: 19.
    OpenUrl
PreviousNext
Back to top
View this article with LENS
Vol 52 Issue 5 Table of Contents
European Respiratory Journal: 52 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
Shamsuddeen A. Aliyu, Ged Avery, Christopher Cawthorne, Stephen J. Archibald, Timor Kadir, Julien M.Y. Willaime, Alyn H. Morice, Simon P. Hart, Michael G. Crooks
European Respiratory Journal Nov 2018, 52 (5) 1801138; DOI: 10.1183/13993003.01138-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
Shamsuddeen A. Aliyu, Ged Avery, Christopher Cawthorne, Stephen J. Archibald, Timor Kadir, Julien M.Y. Willaime, Alyn H. Morice, Simon P. Hart, Michael G. Crooks
European Respiratory Journal Nov 2018, 52 (5) 1801138; DOI: 10.1183/13993003.01138-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Mitochondrial DNA as biomarker of survival in RA-ILD
  • Lung transplantation for cystic fibrosis before and after availability of elexacaftor/tezacaftor/ivacaftor
  • Elexacaftor-tezacaftor-ivacaftor and circulating neutrophil counts in CF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society